Nanovaccine Institute

The Nanovaccine Institute is a consortium based in Ames, Iowa, composed of researchers from public institutions and private companies, coordinated by Iowa State University. With 11 employees, the Institute focuses on developing innovative solutions in the field of nanomedicine. The Nanovaccine Institute specializes in the development of nanovaccines and nanotherapeutics for a wide range of diseases. Their research targets respiratory infections, neural disorders, antimicrobial resistance, cancer, aging, and veterinary diseases. They strive to create groundbreaking treatments that utilize the power of nanotechnology to revolutionize disease prevention and treatment. The Institute's strength lies in its transdisciplinary approach, bringing together experts from diverse fields such as immunology, nanotechnology, materials science, microbiology, neuroscience, cancer biology, gerontology, clinical science, and social science. This collaborative environment fosters innovation and allows for a holistic understanding of complex biological challenges. To learn more about the Nanovaccine Institute and its research, visit their website at nanovaccine.iastate.edu.